Librela 20 mg (Bedinvetmab SOLUTION) 20 MG

Librela 20 mg is a subcutaneous solution containing bedinvetmab, used for managing pain and inflammation in pets. This medication is designed to provide targeted relief for your animal companion.

Strength

20 MG

Manufacturer / TM Owner

ZOETIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Librela 20 mg is primarily used for pain management and inflammation control in pets. It is often recommended for conditions that cause discomfort, such as arthritis or post-surgical recovery. Pet owners frequently ask, 'What is Librela used for?' This medication is formulated to help improve the quality of life for pets experiencing chronic pain.

Side Effects

Librela 20 mg may help reduce pain and inflammation in pets, promoting better mobility and comfort. Some pets may experience improved activity levels and a more relaxed demeanor after administration. As with any medication, individual responses can vary, and it's important to monitor your pet for any changes.

Precautions & Warnings

Librela 20 mg should be administered as directed by a veterinarian. It is important to follow the prescribed dosage and frequency to ensure the safety and effectiveness of the treatment. Always store the medication in a cool, dry place and keep it out of reach of children and pets.

Avoid Interactions

Librela 20 mg may interact with other medications, so it's crucial to inform your veterinarian about any other treatments your pet is receiving. Avoid administering Librela with other pain medications unless specifically instructed by a veterinary professional. Additionally, be cautious when using this medication in pets with known allergies or sensitivities.

Frequently Asked Questions

Librela 20 mg is used for managing pain and inflammation in pets, often for conditions like arthritis or post-surgical recovery.

Librela 20 mg is administered subcutaneously, typically by a veterinarian or trained professional.

Common effects may include reduced pain and inflammation, leading to improved mobility and comfort for pets.

Yes, it's important to follow the prescribed dosage and frequency, and to store the medication properly.

It's important to consult with a veterinarian before using Librela 20 mg with other medications to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.